Diabetes foot care & management: Foot ulcers and amputations are a major cause of morbidity,
disability, as well as emotional and physical costs for people with diabetes. Early recognition and
management of independent risk factors for ulcers and amputations can prevent or delay the onset
of adverse outcomes.
In Cardiac Resynchronization TherapyArrhythmias are irregular heart rhythms and can be caused by
a variety of reasons, including age, heart damage, medications and genetics. In heart failure patients
CRT, or biventricular pacing, is used to help improve the hearts rhythm and the symptoms
associated with the arrhythmia.
Implantable Cardioverter DefibrillatorAn ICD is a battery-powered device placed under the skin that
keeps track of your heart rate. Thin wires connect the ICD to your heart. If an abnormal heart
rhythm is detected the device will deliver an electric shock to restore a normal heartbeat if your
heart is beating chaotically and much too fast. It is important to understand that the decision to
haveangioplastyorcoronary artery bypass graft (CABG) surgeryto treatcoronary artery disease
(CAD)depends on many different things. A healthful eating pattern, regularphysical activity, and
often pharmacotherapy are key components ofdiabetes management. It is best to get vitamins and
minerals from the foods you eat. In fact, research has not been able to prove that dietary orherbal
supplements(including omega-3 supplements, cinnamon, and other herbs) help to manage diabetes.
Related conferences:
12thDiabetesMeeting and Therapeutics Expo September 29-1st october 2016, Canada;11th Asia
PacificDiabetesConferenceand Expo July 11-13 2016,Australia; 6th GlobalDiabetesSummit and
Medicare Expo November 02-04 2015, UAE; 15th GlobalDiabetesSummit and Medicare Expo
November 14-16 2016, UAE; International Conference onTargeting Diabetesand Novel Therapeutics
September 14-16 2015,USA; The 5th World Congress on Controversies to Consensus in Diabetes,
Hypertension andObesityNovember 05-07, 2015,Turkey; 43rd Meeting of the British Society
forPaediatric Endocrinologyand Diabetes November 25-27 2015, UK; DiabeticRetinopathy-Battling
the Global Epidemic September 27 2015, USA; , European Association for the Study ofDiabetesEye
Complications Study Group 26th Annual Meeting June 16-18 2016, UK; International Conference
onMetabolic SyndromesOctober 20-22, 2016,UAE; Diabetes Conferences Europe September 15-17,
2016, Germany
Diabetes and its complications
Gastro paresisis a disorder affecting people with both type 1 andtype 2 diabetesin which the
stomach takes too long to empty its contents (delayed gastric emptying)Diabetic retinopathyis the
most common diabetic eye disease and a leading cause of blindness in American adults. It is caused
by changes in the blood vessels of theretina.Diabetic neuropathyis a type of nerve damage that can
occur if you have diabetes. High blood sugar can injure nerve fibers throughout your body,
butdiabetic neuropathymost often damages nerves in your legs and feet. Currently, diabetic
nephropathy is the leading cause of chronic kidney disease in the United States and other Western
societies. It is also one of the most significant long-term complications in terms of morbidity and
mortality for individual patients with diabetes. Diabetes is responsible for 30-40% of all end-stage
renal disease (ESRD) cases in the United States.
Cardiomyopathyis a condition where the heart muscle is abnormal. The main types of
cardiomyopathy include dilated, hypertrophic and restrictive cardiomyopathy. Cardiomyopathy
makes it harder for your heart to pump and deliver blood to the rest of your body. Cardiomyopathy
can lead to heart failure.Latent autoimmune diabetes in adults(LADA) is a disorder in which, despite
the presence of islet antibodies at diagnosis of diabetes, the progression of autoimmune -cell failure
is slow.
Hypoglycemiais amedical emergencythat involves an abnormally diminished content ofglucosein
theblood. Pregnant women who have never had diabetes before but who have highblood
glucose(sugar) levels during pregnancy are said to havegestational diabetes. According toa 2014
analysis by the Centers for Disease Control and Prevention, theprevalenceofeuglycemia gestational
diabetes conferencesis as high as 9.2%. High blood pressure orhypertensionincreases the risk of
heart disease and stroke. Hypertension risk factors include obesity, drinking too much alcohol,
smoking, and family history. Beta-blockers are a common treatment for hypertension.
Related conferences:
9th GlobalDiabetologistsAnnual Meeting and Medicare Expo June 06-08 2016,USA ; 11th Asia
PacificDiabetesConferenceand Expo July 11-13 2016,Australia; 6th GlobalDiabetesSummit and
Medicare Expo November 02-04 2015, UAE; 15th GlobalDiabetesSummit and Medicare Expo
November 14-16 2016, UAE;Diabetes Conferences Europe September 15-17, 2016, Germany; 11th
International Conference and Exhibition on TargetingDiabetesand Novel Therapeutics October 17-19
2016,Malaysia;Minnesota Midwest AACE Annual Meeting onendocrinologyNovember 21st 2015,
USA;Mid-Atlantic AACE 13th Annual meeting onEndocrinologySep 25-26 2015, USA; AACE New
England annual meeting onendocrinologyNovember 14th 2015, Marlborough;Pediatric
endocrinesociety annual meeting April 29 2016, USA;Obesityand Adipose Tissue Biology February
15-19 2016
Advanced Technologies & Treatments for Diabetes
Blood glucose (bloodsugar) monitoringis the main tool you have to check your diabetes control. This
check tells you yourbloodglucoselevelat any one time. Theartificial pancreasbridges the gap between
two pieces of diabetes technology that already exist: the insulin pump and the continuous glucose
monitor (CGM).Relatively, a large percentage of world population is affected by diabetes mellitus,
out of which approximately 5-10% with type 1 diabetes while the remaining 90% with type 2.Insulin
administrationis essential for type 1 patients while it is required at later stage by the patients of type
2. Currentinsulin delivery systemsare available as transdermal injections which may be considered
as invasive. Several non-invasive approaches for insulin delivery are being pursued by
pharmaceutical companies to reduce the pain, and hypoglycemic incidences associated with
injections in order to improve patient compliance.
Related conferences:
6th GlobalDiabetesSummit and Medicare Expo November 02-04 2015, UAE; 15th
GlobalDiabetesSummit and Medicare Expo November 14-16 2016, UAE; International Conference
onTargeting Diabetesand Novel Therapeutics September 14-16 2015,USA;9th
GlobalDiabetologistsAnnual Meeting and Medicare Expo June 06-08 2016, USA; Euro
GlobalDiabetesSummit and Medicare Expo November 03-05 2015, Spain; New Therapeutics for
Diabetes andObesityApril 17-20, 2016 USA; Diabetes Conferences Europe September 15-17, 2016,
Germany; InternationalConference onDiabetesMellitusSeptember 18-20 2015, China;Pediatric
endocrinesociety annual meeting April 29 2016, USA;Obesityand Adipose Tissue Biology February
15-19 2016; ; International Conference onMetabolic SyndromesOctober 20-22, 2016,UAE
such as glucose tolerability conference, diabetes stem cell cure conference, anti-diabetic agents
meetings, obesity conferences, weight loss conferences, Islet transplantation international
conference, glucose variability conferences etc. Besides that many international events such as
diabetes alternative medicines events, insulin pump therapy events, pancreatic dysfunction events,
recombinant approaches for diabetes events etc. Targeted Therapy Events have been also taking
place in order to find a weapon against fatal diseases like diabetic foot, insulin resistance, glucose
tolerability, obesity and to discuss the role of diabetes in cardiovascular diseases, kidney diseases,
risk of cancer and intolerability to cure the wound which will gives a better insight about the
associated causes and disease portfolio.
Why in Dubai
The UAE has the second-highest diabetes rate in the world, with an estimated 20% of residents and
25% of nationals suffering from the disease. Nearly three-quarters of diabetes patients in the UAE
do not have their diabetes under control, a challenge particularly pronounced among children and
young adults. It is estimated that 40 to 50% of diabetics in the UAE are unaware they even have the
disease. Left unchecked, the spread of diabetes portends devastating social and fiscal consequences,
including threats to economic progress and investment stability in the region.
The United Arab Emirates (UAE) has achieved an impressive level of economic development. In
particular, its healthcare sector is among the best performing in the world. By many measures of
health status (infant mortality, life expectancy, eradication of numerous infectious diseases), the
UAE has reached levels comparable with other developed nations. In addition, the health
infrastructure which includes facilities, equipment, and staff, are of high quality. This healthcare is
offered freely or at low-cost to citizens and highly subsidised to residents and tourists. The fact that
the UAE has made such great strides in achieving a high level of excellence in accommodating the
healthcare needs of so many people is a testament to wise resource management policies. However,
at least one health pandemic threatens to unravel the systems stability: diabetes. The World Health
Organization (WHO) and the International Diabetes Federation (IDF) call diabetes the 21st centurys
leading healthcare challenge. Diabetes complications and mortality create social and economic
challenges that affect individuals, families, businesses, and society as a whole. Six Middle East North
Africa (MENA) region countries Bahrain, Egypt, Kuwait, Oman, Saudi Arabia, and the United Arab
Emirates (UAE) are among the worlds 10 highest for prevalence of diabetes and impaired glucose
tolerance. By 2020, 32% of the adult UAE population (age 20-79) may have diabetes or pre-diabetes,
while other data indicate that the adult UAE population (ages 18 and above) has already reached a
diabetes or pre-diabetes rate of 44%. If trends continue, the IDF projects that by 2030, the number
of people with diabetes in the Middle East North Africa (MENA) region will almost double, reaching
59.7 million.
Diabetes Associations
Major Diabetes Associations around the Globe
Diabetes Australia
Austrian Diabetes Association
Diabetes UK
Diabetes South Africa
Spanish Diabetes Society (Spain)
Swedish Diabetes Association
Korean Diabetes Association